Ask AI

Targeting the MDM2-p53 Pathway in Biliary Tract Cancer: Emerging Data and Implications for Future Clinical Practice

Gain in-depth knowledge on the role of the MDM2/p53 pathway in biliary tract cancer with an expert-authored module and commentary on the rationale for targeting this signaling pathway and the available efficacy and safety data with investigational MDM2 inhibitors in biliary tract cancer.

Share

Program Content

No activities added yet

No activities added yet

No activities added yet

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

Boehringer Ingelheim Pharmaceuticals, Inc.